BIOMAT Database Logo BIOMAT Database Logo

Azathioprine does not potentiate the immunosuppressive effect of 15-deoxyspergualin in rat heart allografting. 1994

G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Department of Transplantation Surgery, Malmö General Hospital, Sweden.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006912 Hydroxyquinolines The 8-hydroxy derivatives inhibit various enzymes and their halogenated derivatives, though neurotoxic, are used as topical anti-infective agents, among other uses. Quinolinols,Chiniofon
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
A new immunosuppressive agent, 15-deoxyspergualin, in dog renal allografting.
June 1989, Transplantation proceedings,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Immunosuppressive effect of 15-deoxyspergualin applied to peripheral nerve allotransplantation in the rat.
March 1995, Experimental neurology,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
February 1991, Transplantation proceedings,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
January 1994, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Immunosuppressive effect and toxicity of 15-deoxyspergualin in cynomolgus monkey.
February 1991, Transplantation proceedings,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Immunosuppressive activities of 15-deoxyspergualin in animals.
April 1987, The Journal of antibiotics,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
February 1995, Transplantation proceedings,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
Immunosuppressive effects of FK 506 and 15-deoxyspergualin in rat lung transplantation.
February 1991, Transplantation proceedings,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
15-Deoxyspergualin and mouse to rat heart retransplantation.
April 1992, Transplantation proceedings,
G Gannedahl, and A Wanders, and J Wadström, and M Olausson, and H Ekberg, and G Tufveson
15-Deoxyspergualin as an immunosuppressive agent in dogs.
February 1988, Transplantation proceedings,
Copied contents to your clipboard!